SB 1350 — Missouri
Enacts provisions relating to insurance coverage of alternatives to opioid drugs
Missouri legislative agenda & upcoming votes Missouri session calendar
Summary
SB 1350 - This act provides that an enrollee's health benefit plan shall not deny coverage of a nonopioid prescription drug in favor of an opioid drug, require the enrollee to try an opioid drug before covering the nonopioid prescription drug, or require a higher level of cost-sharing for a nonopioid prescription drug than for an opioid drug.
This act shall apply to health benefit plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2027.
This act is similar to SCS/SB 841 (2026), SB 902 (2026), the truly agreed to and finally passed HCS/SB 1019 (2026), SB 1449 (2026), SB 158 (2025), the truly agreed to and finally passed HCS/HB 2372 (2026), HCS/HBs 2642, 2296, 1966 & 1680 (2026), HB 804 (2025), and HCS/SS/SB 7 (2025).
TAYLOR MIDDLETON
- SB 1350 is a bill in the Missouri Senate, 2026 session, introduced December 1, 2025.
- Sponsored by Joe Nicola.
- Current status: introduced.
- Most recent action (January 27, 2026): Second Read and Referred S Insurance and Banking Committee.
- Subjects: Drugs and Controlled Substances, Health Care, Health Care Professionals, Insurance - Health, Medical Procedures and Personnel, Pharmacy.
-
State Senator, District 11
Republican
Contact your legislator about this bill
Bill text & documents
Sponsors
Primary: Joe Nicola
History
- Introduced, completed
- Passed Senate, in progress
- Passed House, not reached yet
- Sent to Governor, not reached yet
- Signed into law, not reached yet
- Senate Prefiled
- Senate S First Read
- Senate Second Read and Referred S Insurance and Banking Committee Latest